New

Recombinant Coagulation Factors Market

2021

Recombinant Coagulation Factors Market Forecast to 2028 - COVID-19 Impact and Global Analysis By : Product (Recombinant Factor Viii, Recombinant Factor IX, Von Willebrand Factor); Hemophilia Type (Hemophilia A Hemophilia B); End User (Hospitals, Clinics, Research Institutes)

| Report Code: TIPRE00017828 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Recombinant Coagulation Factors Market 2028 By : Product, Hemophilia Type, End User | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Coagulation factors manufactured in laboratories are termed as recombinant factors. These factors are replace the missing blood clotting factors in Hemophilia. These factors are injected into the vein to help the blood to clot normally. Coagulation factors help to prevent bleeding complications and severe blood loss.

MARKET DYNAMICS

The recombinant coagulation factors market is driving due to the growing number of hemophilia patients, growing prophylactic treatment, and rising demand for diagnosis and prevention of bleeding. Moreover, growing biotechnology and pharmaceutical industry in developed as well as developing countries is likely to create growth opportunities in the market.

MARKET SCOPE

The "Recombinant Coagulation Factors Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Recombinant coagulation factors market with detailed market segmentation by product, hemophilia type, and end user. The recombinant coagulation factors market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Recombinant coagulation factors market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The recombinant coagulation factors market is segmented on the basis of product, hemophilia type and end user. Based on product, the market is segmented as Recombinant Factor Viii, Recombinant Factor IX, and Von Willebrand Factor. The hemophilia type segment is divided into Hemophilia A and Hemophilia B. The end user segment is segmented into hospitals, clinics, and research institutes.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the recombinant coagulation factors Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The recombinant coagulation factors market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting recombinant coagulation factors market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the recombinant coagulation factors market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the recombinant coagulation factors market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from recombinant coagulation factors market are anticipated to have lucrative growth opportunities in the future with the rising demand for recombinant coagulation factors in the global market. Below mentioned is the list of few companies engaged in the recombinant coagulation factors market.

The report also includes the profiles of key players in recombinant coagulation factors market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Baxter International Inc.
  •   Bayer AG
  •   Biogen Idec
  •   CSL Ltd.
  •   Grifols International SA
  •   Kedrion S.P.A.
  •   Novo Nordisk A/S
  •   Octapharma AG
  •   Pfizer Inc
  •   RayBiotech, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Recombinant Coagulation Factors Market - By Product
1.3.2 Recombinant Coagulation Factors Market - By Hemophilia Type
1.3.3 Recombinant Coagulation Factors Market - By End User
1.3.4 Recombinant Coagulation Factors Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RECOMBINANT COAGULATION FACTORS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 Europe - Pest Analysis
4.2.2 Asia-Pacific - Pest Analysis
4.2.3 Middle East and Africa - Pest Analysis
4.2.4 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RECOMBINANT COAGULATION FACTORS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RECOMBINANT COAGULATION FACTORS MARKET - GLOBAL MARKET ANALYSIS
6.1. RECOMBINANT COAGULATION FACTORS - GLOBAL MARKET OVERVIEW
6.2. RECOMBINANT COAGULATION FACTORS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RECOMBINANT COAGULATION FACTORS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. RECOMBINANT FACTOR VIII
7.3.1. Overview
7.3.2. Recombinant Factor Viii Market Forecast and Analysis
7.4. RECOMBINANT FACTOR IX
7.4.1. Overview
7.4.2. Recombinant Factor IX Market Forecast and Analysis
7.5. VON WILLEBRAND FACTOR
7.5.1. Overview
7.5.2. Von Willebrand Factor Market Forecast and Analysis
8. RECOMBINANT COAGULATION FACTORS MARKET - REVENUE AND FORECASTS TO 2028 - HEMOPHILIA TYPE
8.1. OVERVIEW
8.2. HEMOPHILIA TYPE MARKET FORECASTS AND ANALYSIS
8.3. HEMOPHILIA A HEMOPHILIA B
8.3.1. Overview
8.3.2. Hemophilia A Hemophilia B Market Forecast and Analysis
9. RECOMBINANT COAGULATION FACTORS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. RESEARCH INSTITUTES
9.5.1. Overview
9.5.2. Research Institutes Market Forecast and Analysis
10. RECOMBINANT COAGULATION FACTORS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. EUROPE
10.1.1 Europe Recombinant Coagulation Factors Market Overview
10.1.2 Europe Recombinant Coagulation Factors Market Forecasts and Analysis
10.1.3 Europe Recombinant Coagulation Factors Market Forecasts and Analysis - By Product
10.1.4 Europe Recombinant Coagulation Factors Market Forecasts and Analysis - By Hemophilia Type
10.1.5 Europe Recombinant Coagulation Factors Market Forecasts and Analysis - By End User
10.1.6 Europe Recombinant Coagulation Factors Market Forecasts and Analysis - By Countries
10.1.6.1 Germany Recombinant Coagulation Factors Market
10.1.6.1.1 Germany Recombinant Coagulation Factors Market by Product
10.1.6.1.2 Germany Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.1.3 Germany Recombinant Coagulation Factors Market by End User
10.1.6.2 France Recombinant Coagulation Factors Market
10.1.6.2.1 France Recombinant Coagulation Factors Market by Product
10.1.6.2.2 France Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.2.3 France Recombinant Coagulation Factors Market by End User
10.1.6.3 Italy Recombinant Coagulation Factors Market
10.1.6.3.1 Italy Recombinant Coagulation Factors Market by Product
10.1.6.3.2 Italy Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.3.3 Italy Recombinant Coagulation Factors Market by End User
10.1.6.4 Spain Recombinant Coagulation Factors Market
10.1.6.4.1 Spain Recombinant Coagulation Factors Market by Product
10.1.6.4.2 Spain Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.4.3 Spain Recombinant Coagulation Factors Market by End User
10.1.6.5 United Kingdom Recombinant Coagulation Factors Market
10.1.6.5.1 United Kingdom Recombinant Coagulation Factors Market by Product
10.1.6.5.2 United Kingdom Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.5.3 United Kingdom Recombinant Coagulation Factors Market by End User
10.1.6.6 Rest of Europe Recombinant Coagulation Factors Market
10.1.6.6.1 Rest of Europe Recombinant Coagulation Factors Market by Product
10.1.6.6.2 Rest of Europe Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.6.3 Rest of Europe Recombinant Coagulation Factors Market by End User
10.2. ASIA-PACIFIC
10.2.1 Asia-Pacific Recombinant Coagulation Factors Market Overview
10.2.2 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis
10.2.3 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis - By Product
10.2.4 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis - By Hemophilia Type
10.2.5 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis - By End User
10.2.6 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis - By Countries
10.2.6.1 Australia Recombinant Coagulation Factors Market
10.2.6.1.1 Australia Recombinant Coagulation Factors Market by Product
10.2.6.1.2 Australia Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.1.3 Australia Recombinant Coagulation Factors Market by End User
10.2.6.2 China Recombinant Coagulation Factors Market
10.2.6.2.1 China Recombinant Coagulation Factors Market by Product
10.2.6.2.2 China Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.2.3 China Recombinant Coagulation Factors Market by End User
10.2.6.3 India Recombinant Coagulation Factors Market
10.2.6.3.1 India Recombinant Coagulation Factors Market by Product
10.2.6.3.2 India Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.3.3 India Recombinant Coagulation Factors Market by End User
10.2.6.4 Japan Recombinant Coagulation Factors Market
10.2.6.4.1 Japan Recombinant Coagulation Factors Market by Product
10.2.6.4.2 Japan Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.4.3 Japan Recombinant Coagulation Factors Market by End User
10.2.6.5 South Korea Recombinant Coagulation Factors Market
10.2.6.5.1 South Korea Recombinant Coagulation Factors Market by Product
10.2.6.5.2 South Korea Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.5.3 South Korea Recombinant Coagulation Factors Market by End User
10.3. MIDDLE EAST AND AFRICA
10.3.1 Middle East and Africa Recombinant Coagulation Factors Market Overview
10.3.2 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis
10.3.3 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis - By Product
10.3.4 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis - By Hemophilia Type
10.3.5 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis - By End User
10.3.6 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis - By Countries
10.3.6.1 South Africa Recombinant Coagulation Factors Market
10.3.6.1.1 South Africa Recombinant Coagulation Factors Market by Product
10.3.6.1.2 South Africa Recombinant Coagulation Factors Market by Hemophilia Type
10.3.6.1.3 South Africa Recombinant Coagulation Factors Market by End User
10.3.6.2 Saudi Arabia Recombinant Coagulation Factors Market
10.3.6.2.1 Saudi Arabia Recombinant Coagulation Factors Market by Product
10.3.6.2.2 Saudi Arabia Recombinant Coagulation Factors Market by Hemophilia Type
10.3.6.2.3 Saudi Arabia Recombinant Coagulation Factors Market by End User
10.3.6.3 U.A.E Recombinant Coagulation Factors Market
10.3.6.3.1 U.A.E Recombinant Coagulation Factors Market by Product
10.3.6.3.2 U.A.E Recombinant Coagulation Factors Market by Hemophilia Type
10.3.6.3.3 U.A.E Recombinant Coagulation Factors Market by End User
10.4. SOUTH AND CENTRAL AMERICA
10.4.1 South and Central America Recombinant Coagulation Factors Market Overview
10.4.2 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis
10.4.3 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis - By Product
10.4.4 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis - By Hemophilia Type
10.4.5 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis - By End User
10.4.6 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis - By Countries
10.4.6.1 Brazil Recombinant Coagulation Factors Market
10.4.6.1.1 Brazil Recombinant Coagulation Factors Market by Product
10.4.6.1.2 Brazil Recombinant Coagulation Factors Market by Hemophilia Type
10.4.6.1.3 Brazil Recombinant Coagulation Factors Market by End User
10.4.6.2 Argentina Recombinant Coagulation Factors Market
10.4.6.2.1 Argentina Recombinant Coagulation Factors Market by Product
10.4.6.2.2 Argentina Recombinant Coagulation Factors Market by Hemophilia Type
10.4.6.2.3 Argentina Recombinant Coagulation Factors Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RECOMBINANT COAGULATION FACTORS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. RECOMBINANT COAGULATION FACTORS MARKET, KEY COMPANY PROFILES
13.1. BAXTER INTERNATIONAL INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BAYER AG
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BIOGEN IDEC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CSL LTD.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GRIFOLS INTERNATIONAL SA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. KEDRION S.P.A.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. NOVO NORDISK A/S
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. OCTAPHARMA AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PFIZER INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. RAYBIOTECH, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Baxter International Inc.
2. Bayer AG
3. Biogen Idec
4. CSL Ltd.
5. Grifols International SA
6. Kedrion S.P.A.
7. Novo Nordisk A/S
8. Octapharma AG
9. Pfizer Inc
10. RayBiotech, Inc.
TIPRE00017828
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.